Table 2.
Baseline angiographic and echocardiographic characteristics
| Variables | EAT ≥ 3.5 mm | EAT < 3.5 mm | P value |
|---|---|---|---|
| (n = 350) | (n = 411) | ||
| Culprit lesion | |||
| LAD, n (%) | 193 (55) | 224 (55) | 0.86 |
| LCX, n (%) | 32 (9) | 30 (7) | 0.355 |
| RCA, n (%) | 124 (35) | 153 (37) | 0.608 |
| LM, n (%) | 0 (0) | 4 (1) | 0.045 |
| Coronary Artery Disease | |||
| 1 vessel disease, n (%) | 145 (41) | 191 (46) | 0.163 |
| 2 vessel disease, n (%) | 118 (34) | 128 (31) | 0.451 |
| 3 vessel disease, n (%) | 87 (25) | 92 (22) | 0.423 |
| PCI | |||
| BMS, n (%) | 68 (19) | 77 (19) | 0.566 |
| DES, n (%) | 276 (79) | 331 (81) | 0.808 |
| Echocardiographic findings | |||
| LVEDD (mm) | 50 ± 5 | 50 ± 5 | 0.159 |
| LVESD (mm) | 34 ± 6 | 34 ± 6 | 0.3 |
| LVEDV (mL) | 87 ± 19 | 88 ± 23 | 0.789 |
| LVESV (mL) | 45 ± 14 | 45 ± 14 | 0.885 |
| LVMI (g/m2) | 115 ± 28 | 114 ± 32 | 0.554 |
| LVEF (%) | 52 ± 10 | 51 ± 10 | 0.861 |
| WMSI | 1.51 ± 0.34 | 1.52 ± 0.34 | 0.751 |
| Ischemic MR, n (%) | 8 (2) | 7 (2) | 0.565 |
EAT epicardial adipose tissue, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, LM left main artery, PCI primary coronary intervention, BMS bare metal stent, DES drug eluting stent, LVEDD left ventricular end diastolic dimension, LVESD left ventricular end systolic dimension, LVEDV left ventricular end diastolic volume, LVESV left ventricular end systolic volume, LVMI left ventricular mass index, LVEF left ventricular ejection fraction, WMSI wall motion score index, MR mitral regurgitation